Gilead Sciences Inc says it is planning to work with international partners to boost production of its experimental coronavirus drug remdesivir. On Friday, the US Food and Drug Administration (FDA) issued emergency use authorization for the medication made by the California-based company. Remdesivir, which was originally developed as an Ebola drug, is given to hospitalized … Read more
On the heels of an early announcement that coronavirus patients given Gilead’s Ebola drug remdesivir fared better than those who didn’t get the treatment, the company’s CEO, Daniel O’Day, deemed the results a cause for ‘hope at a time when it is badly needed,’ in an open letter obtained by Fox News. ‘Positive data’ from … Read more
Gilead Sciences said that it has capacity to make enough doses of its drug remdesivir for ‘several million treatment courses’ next year in a Thursday press release announcing its first quarter earnings. ‘As Gilead continues to work with international partners to expand production, Gilead announced it anticipates more than one million treatment courses will be … Read more
The antiviral remdesivir has shown promise for treating coronavirus, and the head of the drug’s maker, Gilead Sciences, said he’s committed to ensuring anyone who needs the drug will have access to it. ‘We’re going to work very closely with the government and with health care systems to make sure that it’s accessible, that it’s … Read more
The fight against coronavirus has been an uphill battle. Although we may be past the peak, hundreds are still dying every day, and often there is little doctors can do to save those hit by this mysterious disease. Yet eagerly awaited results of a ground-breaking medical trial have brought fresh hope. US researchers have published early … Read more
President Donald Trump announced Friday that the FDA has approved the experimental drug remdesivir for emergency use in hospitalized coronavirus patients. It is the first drug shown to help fight the disease, which has killed more than 64,000 people in the United States. Gilead’s chief executive officer Daniel O’Day, whose company produces remdesivir joined President Trump, … Read more
The US may approve emergency use of an Ebola drug today after one Oxford academic hailed its trial as a ‘fantastic result’ in the fight against COVID-19. Remdesivir, an antiviral made by California-based Gilead Sciences, was shown to slash recovery times in a global trial of more than 1,000 patients, including Britons. Anthony Fauci, America’s top … Read more
The US Food and Drug Administration (FDA) may announce its decision allowing emergency use authorization of an antiviral drug to treat coronavirus patients as early as Wednesday. It comes after studies showed that remdesivir, made by California-based Gilead Sciences, helped patients go from relying on oxygen to leaving hospital in two weeks, reported The New … Read more
A trial of the antiviral drug remdesivir has produced ‘positive data’ for treating coronavirus patients, its maker, Gilead Sciences, said Wednesday. Gilead announced the results of a clinical trial testing the drug, which was originally developed to treat Ebola patients, in people severely ill with coronavirus. Half of the 397 patients, who were sick enough … Read more
More than half of severely ill coronavirus patients treated with Ebola drug remdesivir recovered and were discharged from hospital within two weeks, trial results reveal Gilead Sciences treated 200 severely ill coronavirus patients with its Ebola antiviral remdesivir Regardless of whether they were treated for five or 10 days, more than half of the patients … Read more